Compounding Best Practices: Choosing the Right Base or Vehicle

Choosing the right vehicle or base for a compounded medication is one of the most critical decisions a pharmacist makes. These choices influence drug release, absorption, stability and the patient’s overall experience using the preparation.

What’s the difference between a base and a vehicle? In compounding, the terms are related but not identical. A vehicle is a carrier, liquid or semi-solid, in which the active pharmaceutical ingredient (API) is dissolved or dispersed, influencing drug release and stability. Purified water, oil-based liquids and cellulose-based gels are all used as vehicles. A base is, typically, a solid or semisolid carrier that holds the API and influences how it is released at the application site. Common examples include cream bases, ointment bases, gel bases, paste bases and suppository bases.

Selecting an appropriate base or vehicle may help support the medication’s effectiveness, stability, and usability, while an unsuitable choice could potentially affect these factors.

So, how can pharmacists make informed choices? Since 1989, Medisca has supported thousands of compounders in preparing millions of prescriptions. Drawing on three decades of compounding experience, here are six practical guidelines for selecting vehicles and bases for compounded medications.

The physical and chemical properties of the API(s) define the range of suitable vehicle or base options. A starting point is whether an API is hydrophilic and lipophilic, but other factors such as pH, melting point, and partition coefficient can also influence the vehicle or base selection.

One of compounding’s strengths is its ability to customize medication to meet patient-specific needs and preferences. This includes taste, texture, allergen or irritant removal, and route of administration. 

A central question is “where does the drug need to act – locally or systemically?” Considering the answer to this question, and often collaborating with the prescriber, will guide which routes, vehicles, and bases are appropriate.

Different bases and vehicles influence the rate at which an API is released and absorbed. 

• Oil-in-water emulsions, such as creams, are less occlusive and more cosmetically pleasing. Lipophilic APIs may partition out of the oil phase and be released relatively quickly, while hydrophilic APIs may release more slowly.
• Water-in-oil emulsions, such as ointments, are more occlusive and increase skin hydration. APIs that are soluble in the oil phase tend to be retained longer, resulting in slower release, while water-soluble APIs may be released more quickly. 
• Gels are typically aqueous, non-occlusive, and fast-drying. APIs that are dissolved in gel matrices are often released relatively quickly. 

Across all types of bases, release and absorption depend on API solubility, partitioning, skin hydration and the use of co-solvents or penetration enhancers. Choosing the right formulation depends on whether a local or systemic effect is desired. 

Compounded medications are most effective when they accommodate patient preferences and tolerability. Medications with unpleasant smells, tastes, or textures can reduce adherence. In addition, sensitivities and allergies to excipients, such as preservatives, lanolin, or emulsifiers, may limit the use of certain commercial bases. While compounded medications cannot meet every possible need, understanding patient preferences and tolerability, and aligning them with optimal vehicle and base options can significantly improve patient adherence.

Stability is a critical consideration in compounded preparations. Resources such as USP Chapter <795> and <797> in the USA, APF 26 in Australia, and NAPRA Model Standards for Pharmacy Compounding provide guidance on non-sterile and sterile compounding and determining beyond-use dates (BUDs). Other resources, such as peer-reviewed stability studies and compounding formularies, offer additional support. 

Reviewing these resources helps determine whether the selected vehicle or base supports the stability and BUD of the compounded preparation.

Bases must be compatible not only with the API but also with other formulation components such as preservatives, stabilizers, buffers, and emulsifiers. Ingredient interactions decrease product effectiveness. For example, the cationic preservative benzalkonium chloride can bind to anionic polymers, reducing its antimicrobial activity even though its total concentration remains unchanged. Understanding these interactions helps ensure that the final preparation performs as intended.

Choosing the right compounding base with confidence

Selecting the appropriate base or vehicle is a critical step in pharmaceutical compounding. It can influence formulation stability, drug delivery, and the overall patient experience. Because each formulation and patient is unique, pharmacists must balance multiple factors, such as API properties, compatibility, route of administration, and patient-specific needs.

Applying the principles outlined above can support more informed decision-making and result in more consistent outcomes. Resources such as the Medisca Base Selector tool, Beyond-Use-Date (BUD) library, and Formulation Support can further  streamline the process — allowing pharmacists to focus on delivering safe, effective, and personalized care. 

Disclaimer: This blog is for general informational and educational purposes only and does constitute professional, regulatory, or medical advice. Any third-party sites referenced in this blog are not monitored or controlled by Medisca and Medisca shall not be held responsible or liable for any content resulting therefrom. Medisca is not liable for any loss or damage arising from the use of or reliance on this content. Medisca makes no guarantees regarding the accuracy or completeness of the information contained herein. At all times, the patient must speak with their physician or qualified healthcare provider to determine if compounding is the suitable treatment for them.